Several cell adhesion-related proteins have been shown to act as tumor-suppressors (TS) in the neoplastic progression of epithelial-derived tumors. Pinin/DRS/memA was ®rst identi®ed in our laboratory and it was shown to be a cell adhesion-related molecule. Our previous study demonstrated that restoration of pinin expression in transformed cells not only positively in¯uenced cellular adhesive properties but also reversed the transformed phenotype to more epithelial-like. Here, we show by FISH analysis that the gene locus for pinin is within 14q13. The alignment of the pinin gene with STS markers localized the gene to the previously identi®ed TS locus D14S75-D14S288. Northern analyses revealed diminished pinin mRNA in renal cell carcinomas (RCC) and certain cancer cell lines. Immunohistochemical examination of tumor samples demonstrated absent or greatly reduced pinin in transitional cell carcinoma (TCC) and RCC tumors. TCC-derived J82 cells as well as EcR-293 cells transfected with full-length pinin cDNA demonstrated inhibition of anchorage-independent growth of cells in soft agar. Furthermore, methylation analyses revealed that aberrant methylation of pinin CpG islands was correlated with decreased/absent pinin expression in a subset of tumor tissues. These data lend signi®cant support to the hypothesis that pinin/DRS/memA may act as a tumor suppressor in certain types of cancers.
Introduction
The gain-of-function oncogenes and the loss-offunction tumor suppressor genes (TSG) are two essential elements of the multistep progression of tumorigenesis. Tumor suppressors are often aected by alterations of the TS locus. These alterations include chromosomal deletions, intragenic mutations, or inactivation of genes by epigenetic mechanisms such as methylation (Levine et al., 1991; Clurman and Groudine, 1997; Haber and Harlow, 1997) . The approximate chromosomal locations of TSGs have been frequently determined by loss of heterozygocity (LOH) analyses (Cavenee, 1993; Fearon, 1997) .
It has been shown that chromosome 14q harbors at least two potential TS loci, one of which is located in the distal 14q31-tel region, and the other in the 14q13 region (Bandera et al., 1997; Chang et al., 1995) . Deletions and translocations of 14q13 have been correlated with kidney adenocarcinomas (Mitelman et al., 1997) . In addition, LOH of the 14q TS locus (D14S75-D14S288) has been correlated with advanced stage transitional cell carcinoma (TCC) (Chang et al., 1995) , nasopharyngeal carcinoma (Mutirangura et al., 1998) , ovarian epithelial tumor (Bandera et al., 1997) , bronchial epithelial tumor (Weaver et al., 1997) , and renal cell carcinoma (Beroud et al., 1996) . The speci®c gene(s) within the 14q13 D segment responsible for the tumor-suppressive activity have not yet been determined.
Alterations in cell ± cell and cell ± matrix adhesive qualities underlie many of the phenotypic changes associated with tumor progression including changes in cell morphology and tissue invasiveness (Ben-Ze'ev, 1997) . Down-regulation of adhesion-related molecules in tumors have indicated that these proteins may function as TSs (Birchmeier, 1995; Bullions et al., 1997; Hoover et al., 1998; Hsieh et al., 1995; Simcha et al., 1996; Taverna et al., 1998) . The loss of E-cadherinmediated cell adhesion was shown to be an important rate-limiting step in the progression of several somatic and hereditary carcinomas (Berx et al., 1998; Birchmeier et al., 1996; Guilford et al., 1998; Hirohashi, 1998; Perl et al., 1998) . Alterations in desmosomal structure and/or composition have been correlated with the invasiveness and metastatic potential of carcinomas (Garrod et al., 1996; Garrod, 1995) . Furthermore, transfections of nonadhesive L929 cells with a combination of desmosomal components inhibit the invasiveness of the cells (Tselepis et al., 1998) . Recently, Degen et al. (1999) have described an alteration in mRNA levels of pinin/DRS/memA in invasive melanomas. Thus, it appears that many cell ± cell adhesion related proteins including desmosomal components are involved in epithelial-derived tumor progression, and alterations in them may contribute to tumor cell invasiveness and metastasis.
Pinin was ®rst identi®ed as a desmosome-associated protein (Ouyang and Sugrue, 1992, 1996) . Cell ± cell adhesion assembly-assay revealed that pinin assembled to pre-formed desmosomes and its localization of desmosomes was correlated with reinforcement of intercellular adhesion and increased IF organization (Ouyang and Sugrue, 1992) . While pinin is associated with mature desmosomes, it is absent from nascent desmosomes, as well as desmosomes of actively migrating epithelial cells (unpublished observations), indicating that pinin is dynamically associated with the desmosome-IF complex. Transfecting full-length pinin cDNA into transformed 293 cells resulted in enhanced cell ± cell adhesion and increased expression of junctional complex-associated proteins (Ouyang and Sugrue, 1996) . It has become evident that pinin/DRS is a cell adhesion-related and nuclear protein (Brandner et al., 1997; Ouyang, 1999; Shi et al., 1997 ), yet functions of pinin's dual localization has yet to be resolved. Nevertheless, it is tempting to speculate that pinin, like other cell adhesion/nuclear proteins such as plakoglobin, and b-catenin (Ben-Ze'ev and Geiger, 1998; Kirkpatrick and Peifer, 1995) , may play a central role in coordinating cell adhesive and nuclear events that are essential in development, tissue remodeling and tumor progression.
Here, we report a detailed analysis of the human pinin gene which is localized to a previously identi®ed 14q TS locus D14S75-D14S288. We also provide evidence supporting the tumor-suppressive activity of pinin in tumorigenesis of various primary tumors. Our data collectively suggest that pinin may play a TS role in certain types of cancer.
Results

Isolation and characterization of the human pinin gene
Detailed organization of the pinin gene was deduced from human genomic clones HG03 and HG07. The gene contains nine exons ranging in size from 72 bp to 2.5 kb, with intron sizes ranging from 70 bp to 1.3 kb, that contain typical TG-AG splice donor/acceptor sites (Figure 1 ). The NCBI UniGene program revealed two UniGene clusters, Hs.44499 (cluster 1) and Hs.83389 (cluster 2), within the 3' portion of the human pinin gene (Figure 1) . Interestingly, three poly(A) + addition sites were found in Unigene cluster 1, and a fourth poly(A) + addition site was located in Unigene cluster 2. We speculate that the clusters Hs.44499 and Hs.83389 present within the pinin gene most likely correlate with the alternative usages of poly(A) + addition sites. There is neither a TATA box nor a CAAT cis-element in the promoter region of the pinin gene, however, a consensus sequence of transcriptional initiation, which is usually present in TATA-less promoters, was found 69 bp upstream of the pinin ATG (translation initiation) (Figure 1 ). The 5' region of the pinin gene, which includes exon 1 and intron 1, contains typical Figure 1 The organization of the human gene for pinin. The structure of the human pinin gene was deduced from a 12 kb sequence obtained from genomic library screenings. The gene contains nine exons, E1 to E9 (solid black boxes), separated by eight introns (solid line). The sizes of exons and introns, the splice donor/acceptor sites are listed (table). Six typical Alu elements (solid circles) are found in non-coding regions. A transcription initiator sequence (Inr) was identi®ed in the ®rst exon and the position of nucleotide A within the Inr is designated as +1. The translational start codon ATG is located at +69. The region in which exon 1 is located displays typical features of CpG islands. CpG islands are enlarged with multiple vertical lines revealing the density and distribution of CpG doublets. Alignment of the CpG152f, a deposited CpG islands sequence in GenBank, is underlined. The stop codon TAA of the ORF is located within exon 9 (nt+6429 to nt+6431). Two NCBI Unigene clusters Hs.44499 (nt *+6300 to *+7000) and Hs.83389 (nt *+7800 to *+8500) were also found within exon 9. The gene sequence is deposited in GenBank under accession number AF195139 CpG islands spanning nucleotide positions *7400 to *+600. The CpG islands are comprised of 71 CpG doublets (Figure 1 , vertical lines) and the CG content was greater than 68%.
Pinin genetic locus
Fluorescence in situ hybridization (FISH) revealed the human pinin gene to reside at 14q13 (Figure 2 , bottom). The sequences of four human STS markers ± STS A005O20, STS SGC31797, STS stSG4334, and STS stSG407 ± were aligned to the human pinin sequence (Figure 2, top) . The pinin gene locus was adjacent to genetic marker D14S306 and within the D segment between markers D14S75 and D14S1053. This D segment has an approximate site of 0.6 cM (HGSI database). Thus, the pinin gene locus was within a 3 cM interval (D14S75-D14S288) that has been previously identi®ed to be a TS locus by a number of studies (Bandera et al., 1997; Beroud et al., 1996; Chang et al., 1995; Mutirangura et al., 1998; Weaver et al., 1997) .
Pinin mRNA levels were depressed in cancer-derived tissues and cancer cell lines
To investigate whether pinin gene expression is aected in primary tumors and tumor cell lines, we examined pinin mRNA levels in epithelial-derived RCC tumors, as well as in a panel of cancer cell lines. Northern blot analyses of four control and four tumor tissues revealed depressed levels of pinin mRNA in two renal cell tumors as compared to their corresponding normal tissue controls (Figure 3a , individuals 1 and 4). Examination of various cancer cell lines also revealed depressed pinin mRNA levels in two of eight cell lines, including a B cell lymphoma cell line (Raji, Figure 3b , lane 5) and a melanoma cell line (G361, Figure 3b , lane 8). The depressed pinin mRNA level in both primary and cancer cell lines suggests that expression of the pinin gene may be dis-regulated in tumorigenesis of certain cancers.
The expression and subcellular localization of pinin were altered in various primary tumor tissues
We conducted immuno¯uorescence studies on a panel of 16 primary tumor samples of various origins. Downregulated pinin expression was observed in transitional cell carcinomas (TCC), renal cell carcinomas (RCC) and some metastasic ovarian tumors. Normal (uninvolved) tissue samples as well as neck region squamous cell carcinoma, colonic adenocarcinoma, and welldierentiated ovarian carcinomas revealed typical desmosomal staining of pinin (Table 1 ). The most dramatic decrease of pinin expression was found in a TCC resected from the renal pelvis. While typical pinin staining was seen in tissue at the tumor margin ( Figure  4a ), no pinin immunoreactivity was detectable in cells comprising most of the tumor mass (Figure 4c ,e). Strikingly, the expression levels of three other major epithelial cell markers, desmoplakin (Figure 4b ), plakoglobin ( Figure 4b ,f), and keratin (not shown), remained similar to normal expression levels throughout the tissue sample. Interestingly, some RCCs also demonstrated decreased pinin expression levels. The Figure 2 Genetic locus of the human pinin gene. The human pinin gene was initially localized to human chromosome 14 at position 14q13 by FISH (bottom) using a 7 kb HG07 genomic fragment of human pinin gene as a probe. The scale of the 14q13 tumor suppressor locus is enlarged (middle). The position and distance of ®ve genetic markers in this region are indicated by black diamonds. The pinin gene (arrowhead) is located adjacent to D14S306, and within the region between the genetic markers D14S75 and D14S288. Four of these genetic markers D14S75, D14S278, D14S306, and D14S288¯anking both sides of the pinin gene locus are targets of LOH in dierent tumors. Within the simpli®ed map of human pinin gene (top), four STS markers (black boxes), the sequences of which were identical to the pinin gene, were used to localize the pinin gene to the 14q13 tumor suppressor locus immunostaining of a representative RCC sample for pinin is shown in Figure 5b ,d.
Remarkably, in a RCC tumor sample, while epithelial cells within collecting ducts exhibited normal pinin staining, the undierentiated tumor cells exhibited aberrant over-expression of pinin with large cytosolic accumulation of pinin immunoreactive material (Figures 6a,b) . However, the intensity and distribution pattern of desmoplakin staining in the pinin over-expressing cells remained largely unaected (Figures 6b,d ).
Exogenous expression of pinin inhibited anchorage-independent growth of J82 and 293 cells
To gain further insight into the tumor suppressor role of pinin, we have conducted soft agar assays to determine the capability of pinin to inhibit anchorage-independent cell growth. TCC-derived J82 cells, which exhibited very low endogenous expression of pinin, were transfected with wt-pinin cDNA (Ouyang and Sugrue, 1996) . Parental cells and the vector-only transfectants grew eciently in soft agar, forming numerous colonies of greater than 100 cells. The pinintransfected J82 cells grew poorly and exhibited very limited colony formation in soft agar (data not shown). To con®rm that the inhibition of anchorage-independent growth was due to the expression of pinin, we generated two cell lines using the ecdysone-inducible mammalian expression system, inducible GFP-only and inducible wt-pinin with C-terminal-tagged GFP (EcR-293-HPGFP). While non-induced ECR-293-GFP and non-induced ECR-293-HPGFP as well as induced ECR-293-GFP cells were able to eciently grow in soft agar (Figure 7a ± c) , the anchorage-independent growth of induced ECR-293-HPGFP cells was suppressed (Figure 7d ).
The detection of aberrant methylation status of pinin CpG islands in several primary tumors
Aberrant methylation of CpG islands preceding tumor suppressor genes has been demonstrated as one of the mechanisms for down-regulating expression of TS genes (Baylin et al., 1998; Herman et al., 1994 ; Kashiwabara et al., 1998; Merlo et al., 1995) . In order to explore the possibility that there is a correlation between aberrant methylation of pinin CpG islands and the down-regulation of pinin, we conducted methylation analysis for the pinin CpG islands. Methylated pinin CpG islands were detected in ®ve out of the previously mentioned 16 primary tumor samples (Table 1 and Figure 8b ). Interestingly, correlation between decreased pinin expression and a methylation of the pinin CpG islands was found in TCC #R10604 and RCC #R413J01 samples. These results suggest that the aberrant methylation may be one mechanism responsible for silencing of the pinin gene.
Discussion
The tumor-suppressive role of the pinin/DRS/memA protein, which was initially based on its genetic locus, has been supported by the demonstration of pinin down-regulation in various primary tumors, the identi®cation of the methylated CpG islands of the pinin gene in the tumor tissues, and the suppression of anchorage-independent growth of tumor cells by transfection of pinin's cDNA. The postulated role of pinin in the reinforcement of epithelial cell ± cell adhesion is consistent with its identi®cation as a potential tumor suppressor. The requisite of down regulation of epithelial cell ± cell adhesion in tumor progression has received much attention over the years (Shiozaki et al., 1996; Tlsty, 1998) . Numerous studies have implicated cell ± cell adhesion as a key regulatory point in the transition from benign to highly invasive tumors. Focus has been directed toward the tumor suppressor role of adhesion molecules such as cadherins, C-CAM, acatenin, and plakoglobin in tumor progression (BenZe'ev, 1997; Davies et al., 1998; Ewing et al., 1995; Simcha et al., 1996) . Conn et al. (1990) demonstrated that the loss of expression of major components of the desmosome correlated with invasiveness of TCC. However, we show in this study that the absence of pinin at desmosomes in a subset of TCC tumor cells occurs without the depression of other desmosomal components. We suggest that pinin may regulate the stability of cell ± cell adhesion and its inactivation may be requisite in certain tumor progressions. The evidence that the pinin cDNA-recipient J82 as well as induced EcR-293-HPGFP cells displayed a suppression of tumorigenic characteristics in soft agar further support that pinin may possess tumor suppressive qualities.
Multiple mechanisms, both genetic and epigenetic, account for the down-regulation of tumor suppressors. In our initial attempt to de®ne the mechanism of decreased pinin levels, we employed Southern analyses and PCR-based genomic sequencing to examine DNA from multiple tumor samples for evidence of intragenic alterations. However, we have not yet identi®ed any genetic alterations that would account for the loss of pinin expression (unpublished data). The detection of aberrant methylation in pinin CpG islands that correlated with lack of pinin expression in TCC and RCC presents one possible mechanism for silencing pinin gene expression. However, the absence of pinin expression in some tumors (e.g. #R106C02) correlated with neither aberrant methylation nor intragenic alterations. Therefore, we will entertain other mechanisms of pinin gene or protein inactivation. Figure 8 Methylation analysis of pinin CpG islands region. A partial map of 5' pinin CpG islands was shown in a. The positions of the HpaII/MspI sites and primers used in this analysis for the detection of methylation are indicated as vertical lines and arrows, respectively. Control PCR primers P1 and P2 are designated to amplify the region (P1 ± P2) of pinin CpG islands not containing HpaII/MspI sites. Primers P3 and P4 are designated to amplify DNA region (P3 ± P4) spanning for HpaII/MspI sites. The presence of a visible PCR product in the U lanes indicates that the primers and PCR condition used to amplify the P1 ± P2 region and the P3-P4 region is proper. The presence of product in the H lanes indicate that the P3 ± P4 region from the tumor sample is insensitive to HpaII digestion, therefore, the sites were methylated. The absence of product in the M lanes indicate that the P3 ± P4 region is sensitive to MspI digestion, therefore, the HpaII/MspI site is present. The presence of product in each lane of lower b served as internal control for each DNA sample and indicates the DNA quality of each sample after digestion is remaining unchanged
The observation that expression of pinin could be depressed or elevated in tumor samples may be a more general phenomenon in tumors. Degen et al. (1999) provided convincing data of the overexpression of pinin/DRS/memA in a subset of melanomas. It should be noted that eight of 11 melanoma metastatic lesions and 13 of 17 tumor cell lines included in this study, actually exhibited depressed or absent expression of pinin/DRS/memA. Here we observed elevated protein expression and uncharacteristic localization of pinin protein within cells comprising a RCC tumor mass. Although it is generally assumed that tumor suppressors are negative regulators of tumor formation and are often down-regulated in cancer development, observations of over-expression of TS proteins such as pRb, p53, p73, p27, p16 in dierent tumors are not uncommon Doki et al., 1997; Kaur et al., 1998; Shapiro et al., 1995; Warneford et al., 1991; Yokomizo et al., 1999) . The over-expression of a tumor suppressor may imply a compensatory mechanism which may function to circumvent the disrupted regulatory pathway of wild-type TS protein (Benedict et al., 1999; Emig et al., 1998) .
Our initial study of pinin expression has revealed that pinin is present in numerous cell types, including those lacking desmosomes (Ouyang and Sugrue, 1996) . Recently, our laboratory and other groups have reported that pinin/DRS/memA is also a nuclear protein (Brandner et al., 1997) . Since pinin expression can be detected in lymphocytes, leukocytes, and in some T cell and B cell leukemias (Ouyang and Sugrue, 1996) , the marked depression of pinin mRNA in Raji cells may indicate involvement of pinin in tumorigenesis of non-epithelial tissue-derived cancers as well. We are currently investigating the possibility that pinin tumor suppressor activity may extend beyond the realm of stabilization of desmosomal adhesions.
Here we presented evidence regarding the involvement of pinin in tumorigenesis and its potential role as a tumor suppressor. We believe this study sheds signi®cant light on the current understanding of the alterations in cell ± cell adhesion which allow for epithelial cells to become invasive. Furthermore, more detailed characterizations of pinin's function in a tumor suppressor pathway may facilitate clinical diagnosis as well as the future design of rational therapies for cancer.
Materials and methods
Identi®cation and isolation of human genomic clones for pinin
A human genomic lambda library (Lambda Fix II, Stratagene) was probed with 32 P-labeled 2.1 kb coding region of human pinin cDNA. The isolation and puri®cation of positive clones were done according to manufacturer's protocol (Stratagene).
Determination of the human pinin gene structure
Two lambda clones, HPG03 and HPG07, were puri®ed and digested with NotI. NotI DNA fragments containing the pinin gene were veri®ed and characterized by Southern blot analysis and subcloned into pBluescript KS (Stratagene). To obtain the entire pinin gene sequence, eight small overlapping restriction fragments were generated and subcloned into pBluescript KS and sequenced.
Northern analyses
Human cancer cell line (Clontech) and human kidney tumor (Invitrogen) Northern blots were probed with 32 P-labeled fulllength human pinin cDNA, and then probed with 32 P-labeled GAPDH cDNA according to manufacturer's protocols. The blots were then subjected to autoradiography using Kodak ®lm (Kodak). The quantitative analysis of pinin and GAPDH expression was conducted using the Quantity One 1 program (BIO-RAD).
Fluorescence in situ hybridization (FISH)
Fluorescence in situ hybridization was done according to standard protocol (Lichter and Cremer, 1992) . The probe used for the hybridization was generated from the genomic DNA fragment HG07 containing coding region of pinin gene by nick translation with digoxigenin-11-2'-deoxy-uridine-5'triphosphate (Boehringer Mannheim, Germany).
Preparation of frozen human tissue sections and immuno¯uorescence microscopy
A total of 17 samples representing dierent stages and grades of TCC, RCC, ovarian, colon, and neck region tumors as well as corresponding uninvolved tissues were obtained from the Tumor Tissue Bank at the University of Florida Cancer Center (Gainesville, FL, USA). Tumor and corresponding uninvolved tissues were embedded in OCT compound and snap frozen in liquid nitrogen. Frozen cryostat sections of 6 mm thickness were ®xed with acetone for 2 min at 720 8C and extensively washed in PBS. Prepared sections were incubated with anti-pinin mAb 08L and/or cell adhesion related antibodies against desmoplakin, plakoglobin, and desmoglein (ARP). Double immuno¯uorescence staining was conducted as described previously (Ouyang and Sugrue, 1992) , using primary Ab mixtures of anti-pinin/antidesmoplakin, or anti-pinin/anti-plakoglobin. Epi¯uorescence microscopy was conducted with a Zeiss Axiophot. Images were digitally captured using a SPOT2 camera (Diagnostic Instruments, Inc.).
Methylation analysis of pinin CpG islands
Methylation analyses were conducted as described by Kane et al. (1997) with minor modi®cations. One mg each of genomic DNA extracted from 16 tumor samples and one uninvolved tissue were endonuclease digested. Reactions containing no enzyme, 100 units of HpaII, or 200 units of MspI were carried out overnight in 50 ml volumes at 378C. Twenty-®ve ng of column-puri®ed DNA from each digest was analysed by PCR. Each 30 ml reaction contained 2 mM MgCl 2 , 10 mM Tris-HCl (pH 8.3), 50 nM KCl, 200 mM dNTPs, 1 unit of Taq polymerase (Boehringer Mannheim) and 3 pmol of primers P3 (5'-CGCCCCGACTCTGCGCTAGCAGC) and P4 (5'-CCGGGCTATGCCGCGCCGCCG). Ampli®cation was conducted as follows: (958C, 4 min)61; [(948C, 45 s), (608C, 45 s), (728C, 45 s)]633; (728C, 7 min)61. PCR products were analysed on 2% agarose gels. Blind assays were conducted as all DNA samples were numbered and coded prior to setting up reactions. PCR reactions and template DNA qualities were controlled by carrying out PCR with the primers P1 (5'-GCATGCGCACCAACAGAATAG) and P2 (5'-GTTAGCTGCGGGTGCCTG). Control PCR reactions were performed in parallel with previous P3-P4 PCR reactions.
Plasmids and constructs
The construct of pinin expression vector pcDNA3-S 2 08L have been previously described (Ouyang and Sugrue, 1996) . The pIND vector is an ecdysone-inducible mammalian expression vector (Invitrogen), and was used to generate pIND-GFP and pIND-HPGFP. The 0.7 kb coding region of humanized GFP (gift from Dr Nick Muzyczka) was ligated to the 3' end of 2.2 kb coding region of human pinin cDNA and this 2.9 kb chimeric cDNA fragment was then cloned into the pIND vector thereby constructing 9 kb pIND-HPGFP. To construct the control pIND-GFP vector, the 0.7 kb coding region of humanized GFP cDNA was cloned into pIND vector.
Cell culture and transfection
The human TCC-derived J82 cell line was purchased from ATCC. Cells were cultured in Dulbecco's modi®ed Eagle medium (BioWhittaker) containing 10% FBS (Mediatech Cellgro), 2 mM glutamine, and 200 U/mL each of streptomycin and penicillin G. The methodology for calcium phosphate transfection and cloning stable transfectants have been previously described (Ouyang and Sugrue, 1996) . EcR-293 cells stably expressing the ecdysone receptor were purchased from Invitrogen and maintained in aforementioned culture medium plus 400 mg/ml of Zeocin (Invitrogen). The EcR-293 cells were transfected with 10 mg of pIND-GFP or pIND-HPGFP by calcium phosphate transfection. Stable transfectants were selected for 4 weeks in the medium containing 400 mg/ml of G418 (Life Technologies) and 400 mg/ml of Zeocin (Invitrogen). Surviving colonies were individually cloned from the stable pool and expanded. For induction of GFP or HPGFP expression, 2 mg/ml of muristerone A (Invitrogen) was added to the cell cultures, and the GFP expression level was reached to maximum after 24 h induction. Clones that demonstrate 100% expression of the green¯uorescent proteins by¯uorescence microscopy were selected for further analysis.
Growth in soft agar
An assay for tumor cell growth in soft agar was conducted as described by Marshall et al. (1977) . Con¯uent monolayers of cultured cells were trypsinized, and single cell suspensions were prepared. Cell suspensions were mixed with DMEM containing 10% FBS and 0.3% agar. In the case for induction of GFP or HPGFP expression, 2 mg/ml of muristeron A was added to the mixture of complete medium and 0.3% soft agar for those induced clones. 1610 5 cells were plated onto a pre-cast 3 ml base of DMEM-10% FBS-0.5% agar in 60 mm petri dishes. Cultures were incubated in a humidi®ed CO 2 incubator at 378C. Cultures were fed at 4-day intervals with DMEM ± 10% FBS ± 0.3% agar or the medium containing muristeron A. Twenty-one days later, colonies greater than 0.1 mm in diameter were counted under low-magnifying microscope. The representative phase contrast photographs were taken from uninduced or induced EcR-293-GFP controls and EcR-293-HPGFP cells. All experiments were repeated three times.
